CD19 and Miyoshi myopathy: Using 1260 newly defined DEGs, we compared the transcriptomes of control plasma cells, POEMS clones (CD138+CD19–HLA-DR–/lo), POEMS nonclones (CD138+CD19+), MGUS, and MM plasma cells.